Titan Pharmaceuticals (NASDAQ:TTNP) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a report published on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Titan Pharmaceuticals stock opened at $5.23 on Monday. The stock’s 50 day moving average price is $3.79 and its 200 day […]
More Stories
PFG Investments LLC Sells 17,827 Shares of NIKE, Inc. (NYSE:NKE)
PFG Investments LLC trimmed its position in NIKE, Inc. (NYSE:NKE – Free Report) by 68.7% in the 1st quarter, according...
Canadian Stocks To Follow Now – June 21st
CSX, Canadian Natural Resources, Raymond James Financial, Canadian Pacific Kansas City, Celsius, Molson Coors Beverage, and Cenovus Energy are the...
Alphabet Inc. (NASDAQ:GOOGL) is Deltec Asset Management LLC’s Largest Position
Deltec Asset Management LLC grew its holdings in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 3.6% in the first quarter,...
Alphabet Inc. (NASDAQ:GOOGL) Shares Bought by World Equity Group Inc.
World Equity Group Inc. increased its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 11.3% in the first quarter,...
Norway Savings Bank Boosts Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Norway Savings Bank raised its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.0% during the 1st...
Appleton Partners Inc. MA Sells 1,172 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Appleton Partners Inc. MA decreased its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.1% during the...